The Incretin Space
A collection of collated data on incretin drug developments, including new drugs, new treatments and the future of incretins in medicine
Written by
The Incretin Space
Featured Posts
Archive
GLP-1
+1
Apr 16, 2026
•
2 min read
ACHIEVEment Unlocked!
Orforglipron reduces the risk of cardiovascular events and all cause death in diabetic patients
GLP-1
+3
Mar 19, 2026
•
7 min read
Retatrutide TRANSCENDS diabetes in first phase 3 trial
A shift in what's possible for diabetes and obesity
GLP-1
+2
Mar 11, 2026
•
11 min read
More amylin updates & more tolerable drugs(finally)?
More early trial results from some new players in the obesity medicine space
